Smith & Nephew PLC
Suletud
1,196.5 1.4
Ülevaade
Aktsiahinna muutus
24h
Min
1194.5
Max
1198.5
Sissetulek | 107M |
---|---|
Müük | 12M 2.8B |
P/E Sektori keskmine | 26.67 41.445 |
Aktsiakasum | 0.376 |
Kasumimarginaal | 3.785 |
Soovitused | Tugev "osta" hinnang |
---|---|
12 kuu keskmine prognoos | +12.34 upside |
Järgmine dividendimakse kuupäev | 8. nov 2024 |
---|---|
Järgmine aktsia dividendi kuupäev (ex-date) | 3. okt 2024 |
Turukapital | -72M 10B |
---|---|
Eelmine avamishind | 1195.1 |
Eelmine sulgemishind | 1196.5 |
Smith & Nephew PLC Graafik
Seotud uudised
Smith & Nephew PLC Prognoos
Hinnasiht
By TipRanks
12.34% tõus
12 kuu keskmine prognoos
Keskmine 1,346.44 GBX 12.34%
Kõrge 1,500 GBX
Madal 1,145 GBX
Põhineb 9 Wall Streeti analüütiku instrumendi Smith & Nephew PLC 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Müük
Müügikulu
Brutokasum müügist
EBITDA
Ärikasum
$
Ettevõttest Smith & Nephew PLC
Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Companys Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Companys Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.